Report Details:
15 Companies Covered
129 Pages
intra-cranial pressure (ICP) monitor Market Overview
The global intra-cranial pressure (ICP) monitor market is projected to grow at a CAGR of 7.42% to reach USD 3.54 billion by 2035.
The market is in its early stages but has witnessed strong growth due to the critical role of ICP monitors in neurosurgery procedures, such as external ventricular draining, cerebrospinal fluid (CSF) circulation, and CSF function assessment.
Rising incidences of traumatic brain injuries, intra-cerebral hemorrhage, meningitis, and neurological disorders are fueling demand. Technological advances, including telemetric monitoring, IoT-enabled devices, AI integration, and smart connected systems, are further boosting market growth.
Government funding, particularly in developing regions, supports R&D for advanced ICP monitors.
Urbanization, industrialization, and rising prevalence of neurological disorders such as Parkinson’s disease, Schizophrenia, and Cerebral Palsy are additional growth drivers. However, high device costs and limited awareness among consumers may constrain market growth.
Global Intra-cranial Pressure Monitor Market – Segmentations
The market is segmented into:
· Techniques: Invasive and Non-Invasive.
· Methods: Intra-Ventricular Catheter, Subdural Screw, Epidural Sensor, among others.
· Applications: Traumatic Brain Injury, Intra-Cerebral Hemorrhage, Meningitis, and others.
· Regions: North America, Europe, Asia-Pacific, Rest of the World (RoW).
Geographical Analysis
· North America: Leading the global ICP monitor market, supported by high healthcare expenditure, strong R&D initiatives, and widespread adoption of advanced monitoring devices. Growth is driven by rising prevalence of neurological disorders.
· Europe: Promising market due to increasing government support, development of advanced monitors, and growth in specialty healthcare services.
· Asia-Pacific: Rapidly emerging market fueled by rising incidence of neurological disorders, growing demand for high-quality medical equipment, and adoption of advanced healthcare technologies.
Competitive Analysis
The ICP monitor market is competitive and fragmented, comprising both small and large players. Companies are adopting strategies such as partnerships, acquisitions, collaborations, product launches, and technology development to gain a competitive edge.
Key Players:
Compumedics Limited (Australia), Covidien Plc. (Ireland), Natus Medical Incorporated (US), Codman & Shurtleff, Inc. (US), Integra LifeSciences Corporation (US), Raumedic (US), and Vittamed.
Industry/Innovation Highlights:
In August 2024, Aesculap, Inc. (a company of B. Braun Melsungen AG), in partnership with Christoph Miethke GmbH & Co. KG (MIETHKE), announced that the M.scio® System, a fully implantable, telemetric intracranial pressure monitoring sensor designed for long-term cerebrospinal fluid (CSF) pressure monitoring in hydrocephalus patients, received the U.S. Food and Drug Administration (FDA) Breakthrough Device Designation. This regulatory milestone signals strong recognition of the clinical potential of non-invasive or long-term ICP monitoring technologies, and it marks a clear strategic push by Aesculap/MIETHKE into the advanced ICP-monitoring segment.
In October 2025, CoMind announced it had raised USD 102.5 million in a funding round aimed at scaling its flagship product, the CoMind One. While the announcement is primarily funding-related, the company highlighted that CoMind One is designed to measure cerebral blood flow, cerebral autoregulation, and intracranial pressure simultaneously, thereby unveiling a next-generation bedside brain monitor that incorporates ICP monitoring within a broader neurological-monitoring ecosystem. This development shows an emerging trend of ICP-monitoring being bundled into integrated neuro-monitoring platforms rather than stand-alone devices.
Key Findings of the Study
· The global ICP monitor market is projected to reach USD 3.54 billion by 2035, growing at a CAGR of 7.42%.
· North America currently dominates the market, driven by high healthcare expenditure, advanced technology adoption, and rising neurological disorder prevalence.
· Europe and Asia-Pacific are promising markets due to government support, specialty healthcare services, and increasing adoption of quality medical equipment.
· Key players include Compumedics, Covidien, Natus Medical, Codman & Shurtleff, Integra LifeSciences, Raumedic, and Vittamed.
· Technological advancements in telemetric, smart, and IoT/AI-enabled devices are shaping the future of ICP monitoring.
· Emerging trend: ICP monitoring is increasingly being integrated into broader neuro-monitoring platforms rather than standalone devices.
Explore In-depth Details: Intra-cranial Pressure (ICP) Monitor Market Research Report